drugset

drugset / Trial / NCT07655960

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults

NCT07655960 ↗

Phase 1 Completed 41 enrolled AJU Pharm Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults

Timeline

Start: 2026-06-11
Primary completion: 2026-06-19
Completion: 2026-07-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AJU-C716	Unknown	—	—
Subject	C716R	Unknown	—	—

Indications